Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,142.85
-7.0000-0.61%
Post-market: 1,143.600.7540+0.07%19:59 EDT
Volume:2.05M
Turnover:2.35B
Market Cap:1.08T
PE:38.36
High:1,164.92
Open:1,153.82
Low:1,136.66
Close:1,149.85
52wk High:1,292.65
52wk Low:783.85
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.92
T/O Rate:0.22%
Dividend:6.69
Dividend Rate:0.59%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:31.89
PE(LYR):49.80

Loading ...

Eli Lilly Canada: Continues to Take Action to Address Promotion and Sale of Unapproved and Illegal Retatrutide Products in Canada

THOMSON REUTERS
·
Aug 17

PRESS Digest-Canada - August 17

Reuters
·
Aug 17

Leal Therapeutics: Raises $30M in Series a Extension Financing, Adds Eli Lilly as New Investor

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase Iii Clinical Trials for Adult Depression Treatment Brenipatide in China - Notice

THOMSON REUTERS
·
Aug 17

Eli Lily Initiates New Phase III Clinical Trials for Brenipatide in China

Reuters
·
Aug 17

The Mediterranean Diet is the Best One Out There. Here's Why Americans Struggle with It.

Dow Jones
·
Aug 17

Eli Lilly Launches New Phase III Trial in China for Its Once-Daily Depression Candidate

Stock News
·
Aug 17

Top Premarket Gainers

MT Newswires Live
·
Aug 17

OmniAb Enters $370‑Million Drug‑Development Deal With Eli Lilly

Reuters
·
Aug 17

OmniAb Signs Global Ion Channel Collaboration Deal with Eli Lilly, Eyes up to $370 Million in Milestones

Reuters
·
Aug 17

Bristol Gate’s Richard Hamm Trims Eli Lilly Stake

TIPRANKS
·
Aug 15

Mirova US LLC trims Eli Lilly position by 14,395 shares

TIPRANKS
·
Aug 15

PRIMECAP Management Co trims Eli Lilly stake by 50K

TIPRANKS
·
Aug 15

Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 15

Eli Lilly & Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

Eli Lilly’s New Phase 1 Study Signals Ongoing Pipeline Expansion

TIPRANKS
·
Aug 15

Lilly Expands Obesity Pipeline With Fresh Macupatide Trial in Japan

TIPRANKS
·
Aug 15

China Merchants Adjusts Eli Lilly Price Target to $1,252 From $964, Maintains Buy Rating

MT Newswires Live
·
Aug 14

UBS Pursues Dual Strategy in Q2: Betting on AI Compute Boom While Hedging Crowded Trade Risks

Stock News
·
Aug 14

Eli Lilly & Co (LLY) Gets a Buy from Barclays

TIPRANKS
·
Aug 14